Summary

● The company usually posts poor financials for mid or long term investments.


Strengths

● The stock, which is currently worth 2017 to 0.53 times its sales, is clearly overvalued in comparison with peers.

● Analysts covering this company mostly recommend stock overweighting or purchase.

● The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.


Weaknesses

● Stock prices approach a strong long-term resistance in weekly data at EUR 4.7.

● As estimated by analysts, this group is among those businesses with the lowest growth prospects.

● Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.

● Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.

● For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.

● For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.

● For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.

● The underlying tendency is negative on the weekly chart below the resistance at 4.7 EUR